APP/PS1 mouse model of AD amyloidosis show an upregulation and activation of A2A adenosine receptors hampering long-term synaptic potentiation (LTP) in hippocampal CA3 pyramidal cells (Viana da Silva et al., 2016). Here, APP is linked to Alzheimer disease.